21Shares has filed for a new spot Injective (INJ) ETF with the US Securities and Exchange Commission. The ETF issuer submitted the application on October 20, 2025, making Injective one of the altcoins with multiple ETF applications before the SEC. INJ trades at $8.75 as cryptocurrencies look to bounce off recent lows amid ETF-fueled bullish [...]The post Injective news: 21Shares files for a new INJ ETF appeared first on CoinJournal.